Trial: 202005165

Phase II Trial with Safety Lead-in of Duvelisib Maintenance after Autologous Stem Cell Transplant in T-Cell and Indolent B-Cell Lymphomas

Phase

II

Principal Investigator

Cashen, Amanda

Disease Site

Non-Hodgkin’s Lymphoma

Learn more about this study at: clinicaltrials.gov